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Abstract The effect of cytokines on the taurine uptake by
human intestinal epithelial Caco-2 cells was investigated. Among
the various cytokines tested, tumor necrosis factor K (TNF-K)
markedly increased the taurine uptake by Caco-2 cells, resulting
in an increase in the intracellular taurine level. TNF-K did not
induce up-regulation of the taurine uptake in hepatic HepG2,
renal human embryo kidney 293, and macrophage-like THP-1
cells. The uptake of glycine, L-leucine, and L-glutamic acid by
Caco-2 cells was not affected by TNF-K. A kinetic analysis of
the taurine uptake by TNF-K-treated Caco-2 cells suggests that
this up-regulation was associated with both an increase in the
amount of the taurine transporter (TAUT) and an increase in its
affinity. TNF-K-treated cells showed a higher mRNA level of
the TAUT than did the control cells. ß 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Taurine (2-aminoethanesulfonic acid), one of the major in-
tracellular L-amino acids in mammals, is believed to be essen-
tial, particularly for the growth of fetuses and newborns.
Taurine is involved in a variety of biological phenomena
such as osmoregulation, antioxidation, detoxi¢cation, neuro-
nal modulation, cell proliferation and cell viability [1,2].
Taurine is known to be transported by a speci¢c transport-
er, the taurine transporter (TAUT). TAUT has been cloned
from the brain [3,4], kidney [5], thyroid [6], and placenta [7].
We have cloned human intestinal TAUT in a form almost
identical to that in other organs and demonstrated its regu-
latory characteristics in intestinal epithelial Caco-2 cells such
as hypertonicity-induced up-regulation [8] and taurine-in-
duced down-regulation [9]. We have also found that the taur-
ine uptake was inhibited by food-derived substances and
identi¢ed the inhibitory substance in sesame seeds as lyso-
phosphatidylcholine [10].
In addition to these regulatory factors, another factor could
contribute to the regulation of taurine transport; cytokines
are candidates for TAUT regulators, because there have
been several reports on cytokine-induced regulation of amino
acid transport. For example, the L-arginine uptake by vascular
smooth muscle cells is regulated by tumor necrosis factor K
(TNF-K), interleukin 1L (IL-1L) and tumor growth factor L
(TGF-L) [11,12]. Kohan et al. [13] have also reported that
IL-1 increased the D-aspartate uptake by the mouse renal ep-
ithelium. A highly developed immune system is known to
work in the intestinal tract, where T lymphocytes, macro-
phages, ¢broblasts and intestinal epithelial cells secrete vari-
ous cytokines in response to extracellular stimulation [14^17].
Under such pathogenic conditions as in£ammatory bowel dis-
eases (IBD), the cytokine pro¢le may dramatically change
[18]. It is therefore possible that intestinal epithelial cells are
frequently exposed to unusually high concentrations of cyto-
kines secreted by other immunocompetent cells. However, the
regulatory properties of intestinal TAUT by cytokines have
not previously been reported.
The regulation of taurine uptake by cytokines was therefore
investigated in the present study, and we found that TNF-K
markedly increased the taurine uptake by human intestinal
Caco-2 cells. The characteristics and mechanism for this reg-
ulation were investigated, and its physiological signi¢cance is
also discussed.
2. Materials and methods
2.1. Materials
The Caco-2 cell line was obtained from the American Type Culture
Collection (Rockville, MD, USA), and Dulbecco’s modi¢ed Eagle’s
medium (DMEM) was purchased from Sigma (St. Louis, MO, USA).
Penicillin^streptomycin (10 000 U/ml and 10 mg/ml in 0.9% sodium
chloride, respectively) and non-essential amino acids were purchased
from Gibco (Gaithersburg, MD, USA). Fetal calf serum was pur-
chased from Asahi Technoglass (Chiba, Japan). [1,2-3H]Taurine (spe-
ci¢c radioactivity 29 Ci/mmol), [2-3H]glycine (25 Ci/mmol), L-[4,5-
3H]leucine (155 Ci/mmol), L-[G-3H]glutamic acid (49 Ci/mmol) and
[K-32P]dCTP were all from Amersham (Little Chalfont, UK). Human
TNF-K, IL-1L, interleukin 5 (IL-5), interleukin 8 (IL-8), interleukin 15
(IL-15), TGF-L, and interferon Q (IFN-Q) were all purchased from
Pepro Tech., Inc. (Rocky Hill, NJ, USA). All the other chemicals
used were of reagent grade.
2.2. Cell culture
Caco-2 cells were cultured at 37‡C in a humidi¢ed atmosphere of
5% CO2 in air with a culture medium consisting of DMEM, 10% fetal
calf serum, 1% non-essential amino acids, 2% glutamine, 200 U/ml of
penicillin, 200 Wg/ml of streptomycin and an appropriate amount of
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sodium bicarbonate. HepG2, human embryo kidney 293 (HEK293),
and THP-1 cells were cultured in the same medium as that for Caco-2,
except that the non-essential amino acids were excluded. These cells
were cultured at a density of 1.4U105 cells/well in 24-well plates that
had been precoated with collagen and then used for the uptake experi-
ments. The Caco-2 monolayers for the uptake experiments were used
after 14 days of culture, the HepG2 cells after 5 days of culture, and
the HEK293 cells after reaching 70^80% con£uence. The THP-1 cells
were di¡erentiated to adherent cells by treating with 200 WM phorbol
12-myristate 13-acetate for 2 days before being used for the uptake
experiment.
2.3. Uptake experiments
[3H]Taurine uptake experiments were performed in the absence (to-
tal uptake) or presence (non-speci¢c uptake) of 50 mM unlabeled
taurine, thus allowing the speci¢c uptake to be calculated by subtrac-
tion. The cells were washed twice with 700 Wl each of Hank’s balanced
salt solution containing 4 mM sodium bicarbonate and 10 mM
HEPES, the pH value being adjusted to 7.4 with potassium hydroxide
(uptake bu¡er). The cells were then incubated at 37‡C for 10 min with
0.3 WCi of [3H]taurine in 300 Wl of the uptake bu¡er, with or without
50 mM taurine. At the end of the incubation period, the bu¡er was
removed, and each monolayer was carefully washed three times with
700 Wl each of ice-cold phosphate-bu¡ered saline (PBS) containing
0.05% sodium azide for 5 min. To each well was then added 250 Wl
of 0.1% Triton X-100, before the dissolved cells were taken into 3 ml
of a scintillation cocktail. The tritium content of each monolayer was
¢nally determined with an LSC 5100 liquid scintillation analyzer (Alo-
ka, Tokyo, Japan).
2.4. Measurement of the intracellular content of amino acids
To measure the intracellular content of amino acids, Caco-2 cells
cultured in six-well plates for 14 days were used. The cells were rinsed
twice with PBS and rendered soluble with 0.1% Triton X-100. The
resulting cell homogenate was mixed with an equal volume of 10%
trichloroacetic acid and centrifuged at 10 000Ug for 10 min. The
amino acid content of the supernatant was measured with an
L-8500 high-speed amino acid analyzer (Hitachi, Japan).
2.5. Northern blot analysis
Poly(A) RNA (10 Wg) that had been fractionated on 1% agarose
gel containing 2.2 M formaldehyde was transferred to a nylon ¢lter
(Hybond-N, Amersham) according to the manufacturer’s instructions.
The ¢lter was hybridized with the polymerase chain reaction product
of the human TAUT [7] that had been labeled by randomly priming
with an [K-32P]dCTP labeling kit (Multiprime, Amersham). After
treating in a hybridization solution (Rapid, Amersham) at 65‡C for
3 h, the ¢lter was washed in 0.1USSC containing 0.1% sodium do-
decyl sulfate at 65‡C.
3. Results
3.1. E¡ect of cytokines on the taurine uptake by Caco-2 cells
Caco-2 cells after 14 days of culture were incubated with
the various cytokines for 24 h each, and uptake experiments
were then performed. Among the cytokines tested, TNF-K
and IL-1L, respectively, increased the taurine uptake activity
by 200% and 160% of the control value (Fig. 1). The time-
Fig. 1. E¡ect of various cytokines on the taurine uptake by Caco-2
monolayers. Cells were precultured for 24 h in a medium containing
various TNF-K (50 ng/ml), TGF-L (50 ng/ml), IL-1L (50 ng/ml),
IL-5 (50 ng/ml), IL-8 (50 ng/ml), IL-15 (50 ng/ml), or IFN-Q (1000
U/ml). Uptake experiments were then performed as described in
Section 2. Each value is the mean þ S.E.M. (n = 4).
Fig. 2. Time- and concentration-dependence of the TNF-K-induced
up-regulation of taurine uptake in Caco-2 monolayers. A: Caco-2
cells were precultured in a medium containing TNF-K (50 ng/ml)
for various times (0^48 h), and uptake experiments were performed
as described in Section 2. Each value is the mean þ S.E.M. (n = 4).
B: Cells were precultured for 24 h in a medium containing various
concentrations of TNF-K. Uptake experiments were then similarly
performed. Each value is the mean þ S.E.M. (n = 4).
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and concentration-dependence of TNF-K-induced up-regula-
tion of the taurine uptake by Caco-2 cells was then examined.
The cells were incubated with 50 ng/ml of TNF-K for 0^48 h,
and the taurine uptake activity was measured. The taurine
uptake increased in a time-dependent manner from 0 to 24 h
and reached a plateau after 24 h (Fig. 2A). The cells were also
incubated with di¡erent concentrations of TNF-K (1^100 ng/
ml) for 24 h before the uptake experiments. As shown in Fig.
2B, the taurine uptake increased as the concentration of TNF-
K exposed to Caco-2 increased. The activity reached nearly
200% of the control value when the cells were exposed to a
10 ng/ml or higher concentration of TNF-K.
3.2. E¡ect of TNF-K on the uptake and cellular accumulation
of other amino acids
We investigated the e¡ect of TNF-K on the uptake of gly-
cine (Gly), L-leucine (L-Leu), and L-glutamic acid (L-Glu) by
Caco-2 cells. As shown in Fig. 3, TNF-K had no e¡ect on the
Gly, L-Leu, or L-Glu uptake, whereas the taurine uptake was
markedly increased.
The intracellular amino acid content in Caco-2 cells cul-
tured with TNF-K was next measured. Among the various
amino acids, only the taurine content signi¢cantly increased
in TNF-K-treated cells, reaching 130% of the control value
(data not shown). This increase was dependent on the culture
time with TNF-K (data not shown).
3.3. E¡ect of TNF-K on the taurine uptake by HepG2,
HEK293, and THP-1 cells
The TAUT is expressed not only in the intestines but also
in other tissues. We therefore investigated whether the taurine
uptake by human hepatoma HepG2, HEK293, and human
macrophage-like (THP-1) cells was also up-regulated by
TNF-K. However, little or no change was observed in the
taurine uptake by these cells (Fig. 4), suggesting that the
TNF-K-induced up-regulation of taurine uptake was tissue
speci¢c.
3.4. Kinetics of the taurine uptake by Caco-2 cells cultured with
TNF-K
A kinetic analysis of the taurine uptake was performed on
cells cultured with or without 50 ng/ml of TNF-K for 24 h.
The Vmax value for the control cells was 417 pmol/mg of
protein/10 min, and the Km value was 17.3 WM. For the
TNF-K-treated cells, the Vmax and Km values were 769 pmol/
mg of protein/10 min and 11.9 WM, respectively (Table 1).
These results indicate that the TNF-K-induced up-regulation
of the taurine uptake was mainly due to an increase in the
number of cell-surface TAUTs, although a change in the af-
¢nity of the TAUT was also likely to have been involved in
this regulation.
3.5. Expression level of TAUT mRNA in Caco-2 cells cultured
with TNF-K
The Northern blot analysis was performed to determine
whether or not this phenomenon was associated with a change
in the expression level of TAUT mRNA. Poly(A) RNA
(10 Wg) extracted from Caco-2 cells that had been cultured
in a medium with 50 ng/ml of TNF-K for 0^24 h was used.
Fig. 5 shows that the expression level of TAUT mRNA was
markedly increased by the TNF-K treatment in a time-depen-
dent manner. This suggests that the up-regulation of taurine
uptake by TNF-K was attributable to the increased expression
level of TAUT mRNA.
4. Discussion
We investigated in the present study, using human intestinal
Caco-2 cells, whether cytokines regulated the taurine uptake
by the intestinal epithelial cells. The results show that TNF-K
markedly increased the taurine uptake by Caco-2 cells. The
up-regulation by TNF-K was taurine speci¢c and also tissue
speci¢c, and is likely to have been due to an increase in the
maximal velocity of the TAUT, as well as due to a change in
the a⁄nity. The TNF-K-induced increase in the expression
level of TAUT mRNA would account for this increase in
the Vmax value, although the cellular events in the TNF-K-
induced up-regulation of TAUT have not yet been revealed.
Since TNF-K is known to activate nuclear factor UB
(NFUB), one of the important transcriptional factors [19],
activation of the NFUB pathway may be involved in this
regulation. Our preliminary experiment has demonstrated
that the TNF-K-induced increase in the taurine uptake was
diminished by treating the cells with speci¢c inhibitors of the
Table 1
Kinetic analysis of the taurine uptake by TNF-K-treated and control cells
Control TNF-K-treated
Vmax (pmol/mg of protein/10 min) 417 769
Km (WM) 17.3 11.9
Cells were precultured in a medium containing 50 ng/ml of TNF-K for 24 h. The taurine uptake by the TNF-K-treated and control cells was
then measured over the concentration range of 1^50 WM taurine.
Fig. 3. E¡ect of TNF-K on the uptake of various amino acids by
Caco-2 cells. Cells were precultured for 24 h in a medium with
50 ng/ml of TNF-K (+TNF) or without (Con.). Uptake experiments
were then similarly performed. Each value is the mean þ S.E.M.
(n = 4).
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NFUB pathway such as pyrrolidinedithiocarbamate, thus sup-
porting this hypothesis. Cloning and characterization of the
promoter region of the human intestinal TAUT gene are now
in progress to obtain more direct evidence for the participa-
tion of NFUB in the regulation of TAUT gene transcription.
TNF-K had little or no e¡ect on the taurine uptake by
human hepatic, renal and immune cell lines as shown in
Fig. 3, suggesting that this phenomenon was speci¢c to the
intestinal epithelial cells. During this study, however, Chang
et al.[20] have reported that the taurine uptake by rat astro-
cytes was increased by TNF-K, although the behavior or reg-
ulation of the TAUT in this phenomenon has not been ana-
lyzed in their paper. This ¢nding, however, indicates that the
TNF-K-induced up-regulation of TAUT is not always re-
stricted to the intestinal epithelial cell, and that nerve cells
also possess a similar mechanism. This may suggest that taur-
ine plays a similar or common physiological role in these two
types of cells.
The physiological signi¢cance of the up-regulation of
TAUT is most interesting. It is known that an in£ammatory
condition called ‘controlled in£ammation’ [21] takes place in
the intestines due to cytokine-mediated interaction between
lamina propria lymphocytes and epithelial cells, although
the intestinal in£ammatory reactions are usually balanced
and regulated by various cytokines [22]. TNF-K plays a key
role in the development of in£ammation. TNF-K, as well as
IL-1 and interleukin 6 (IL-6), increase the ability of epithelial
cells, endothelial cells, macrophages and B cells to secrete
potent chemokines such as IL-8 and monocyte chemotactic
protein-1, by which macrophages and granulocytes are moved
to the in£amed mucosa. Isaacs et al. [23] have shown a more
frequent occurrence of TNF-K, IL-1 and IL-6 in IBD patients
than in normal patients. Several clinical studies have also
demonstrated that anti-TNF-K therapy reduced the symptoms
in IBD patients [24]. These ¢ndings suggest the importance of
TNF-K in the development of in£ammation.
The intestinal in£ammation induced by TNF-K is accom-
panied by disruption of the intestinal epithelial barrier func-
tions [25]. Apoptosis in the epithelial cells induced by TNF-
K would be one of the reasons of this disruption. Interest-
ingly, TNF-K also negatively regulates apoptosis by activat-
ing NFUB. Soler et al. [26] have reported that disruption of
the epithelial barrier function caused by TNF-K was self-
recovered and that the restoration of the barrier was due
to the activation of NFUB. Our experimental results suggest
that the NFUB activation was linked to the up-regulation of
TAUT. Taken together, the TNF-K-induced increase in the
intracellular taurine concentration may play a role in the
NFUB-induced restoration of the epithelial barrier function,
because taurine is an intracellular antioxidant and also an
anti-in£ammatory agent with anti-apoptotic activity [27]. The
up-regulation of TAUT could therefore be a reasonable re-
sponse for intestinal epithelial cells under in£ammatory con-
ditions.
It has been reported that proin£ammatory cytokines such
as TNF-K and IL-8 were expressed in intestinal epithelial cells
in response to bacterial invasion and were up-regulated after
TNF-K stimulation [28]. Seabra et al. [29] have reported that
taurine blunted the lipopolysaccharide-induced increase in
TNF-K by Kup¡er cells. If taurine suppresses the excess pro-
duction of such in£ammatory cytokines as TNF-K in the in-
testinal epithelial cells as well, the up-regulation of TAUT by
TNF-K would also be a reasonable response.
In conclusion, we found for the ¢rst time that the human
intestinal TAUT was up-regulated by TNF-K and that the
expression of TAUT mRNA was also up-regulated. Studying
the regulatory mechanism and its physiological signi¢cance
may lead to ¢nding new functions of taurine.
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